May 7, 2024 Beckman Coulter and MeMed Extend Partnership Advancing Host Immune Response Diagnostics View Article
November 6, 2023 MeMed Bolsters Leadership Team With Appointment of Ori Hadomi as Chairman and Peter Scheu as President of MeMed US View Article
July 19, 2023 FDA clearance opens up MeMed’s bacteria-versus-virus blood test to the point-of-care View Article
May 30, 2023 Nutex Health Inc. Announces Agreement with MeMed to Adopt Pioneering MeMed BV® Test Across its Network of 19 sites View Article
April 18, 2023 Clinical data validate pioneering MeMed BV technology improves diagnosis of pediatric patients with fever in the Emergency Department View Article
February 20, 2023 Accessible Diagnostic Distinguishes Bacterial and Viral Infections through Host Immune Response View Article
July 22, 2022 DiaSorin Receives FDA 510(K) Clearance for Its LIAISON® MeMed BV® Test the First High Throughput Blood Test to Differentiate Between Bacterial and Viral Infections View Article
